Case Challenges in Psoriasis and Psoriatic Arthritis

Title:

Case Challenges in Psoriasis and Psoriatic Arthritis

Topic: Dermatology
Relevant Terms: psoriasis, psoriatic arthritis
Primary Audience: Dermatologists, rheumatologists, primary care physicians, physician assistants (PAs), nurse practitioners (NPs), registered nurses (RNs) and other clinicians managing patients with psoriasis and/or psoriatic arthritis
Launch Date: 12-Jun-15
Credits: 0.75 AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Improving Outcomes in Psoriasis and Psoriatic Arthritis

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Determine the severity of skin and joint symptoms in patients diagnosed with psoriasis and PsA
  2. Assess the benefits and risks of available therapies for individual patients with moderate to severe psoriasis and PsA

    Faculty

    Philip J. Mease, MD
    Chief of Rheumatology Research
    Swedish Medical Center
    Clinical Professor of Medicine
    University of Washington
    Seattle, WA
    Alan Menter, MD
    Chief, Division of Dermatology
    Baylor University Medical Center
    Clinical Professor of Dermatology
    University of Texas, Southwestern Medical School
    Dallas, TX
    Daniel Furst, MD
    Carl Pearson Professor of Medicine
    Director, Rheumatology Clinical Research Center
    Los Angeles, CA
    This activity is supported by independent educational grants from Celgene Corporation and AbbVie.
     
    CONTINUING MEDICAL EDUCATION
    Accreditation Statement
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and MCM Education. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation
    The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
     
    Credit is awarded to participants who score 75% or better on the post-test.

    The online activity will take approximately 45 minutes to complete.

    DISCLOSURES
    It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational activities. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and the credit providers have a process in place to resolve any conflict of interest.
     
    Philip Mease, MD, discloses the following:
    Grant/Research Support: Abbott Laboratories, Amgen Inc, Biogen Idec Inc, Bristol-Myers Squibb Company, Centocor Ortho Biotech Inc, F. Hoffman La Roche Ltd, Genentech Inc, Pfizer Inc, UCB Inc, Wyeth Pharmaceuticals; Consultant: Abbott Laboratories, Amgen Inc, Biogen Idec Inc, Bristol-Myers Squibb Company, Centocor Ortho Biotech Inc, F. Hoffman La Roche Ltd, Genentech Inc, Pfizer Inc, UCB Inc, Wyeth Pharmaceuticals; Speakers' Bureau: Abbott Laboratories, Amgen Inc, Biogen Idec Inc, Bristol-Myers Squibb Company, Centocor Ortho Biotech Inc, Genentech Inc, Pfizer Inc, UCB Inc, Wyeth Pharmaceuticals
     
    Daniel Furst, MD, discloses the following:
    Consultant: Abbott, Actelion, Amgen, Biogen Idec, Bristol-Myers Squibb, Centocor, CORRONNA, Genentech, Gilead, GlaxoSmithKline, National Institutes of Health, Novartis, Pfizer, Roche, UCB
     
    Alan Menter, MD discloses the following:
    Advisory Board: AbbVie, Allergan, Amgen, Boehringer Ingelheim, Genentech, Janssen Biotech, Inc., LEO Pharma, Pfizer; Consultant: AbbVie, Allergan, Amgen, Convoy Therapeutics, Inc., Eli Lilly, Janssen Biotech, Inc., LEO Pharma, Novartis, Pfizer, Syntrix, Wyeth, XenoPort; Investigator: AbbVie, Allergan, Amgen, ApoPharma, Boehringer Ingelheim, Celgene, Convoy Therapeutics, Inc., Eli Lilly, Genentech, Janssen Biotech, Inc., LEO Pharma, Merck, Novartis, Pfizer, Symbio/Maruho, Syntrix, Wyeth; Speaker: AbbVie, Amgen, Janssen Biotech, Inc., LEO Pharma, Wyeth

    The University of Chicago Pritzker School of Medicine staff involved in the development and review of this activity have nothing to disclose.
    Joshua Kilbridge, Medical Writer, has nothing to disclose.
    Kathleen Hines, MCM Education Editorial Director, has nothing to disclose.

    Faculty members are required to inform the audience when they are discussing off-label or unapproved uses of devices or drugs. Devices or drugs that are still undergoing clinical trials are identified as such and should not be portrayed as standard, accepted therapy. Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing physician to monitor the medical literature to determine recommended dosages and uses of the drugs. Neither the publisher nor the providers promote the use of any agent outside of approved labeling.

    DISCLAIMER
    The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, The University of Chicago Pritzker School of Medicine, Celgene, or AbbVie. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer's product information, and comparing any therapeutic approach with the recommendations of other authorities.

    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 6+ for Mac OSX 10.7 and above

    For video playback, install the latest version of Flash or Quicktime.
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above